Correspondence from Kathy Hibbs, Chief Legal and Regulatory Officer, 23andMe, relating to Commercial genomics follow-up

Published:	Thursday 21 May 2020 @ 11:00
Publication type:	Correspondence
Committee:	Science, Innovation and Technology Committee

Work packages